NBIX (Neurocrine Biosciences) Net earnings per share growth this year

NBIX (Neurocrine Corp) - company brandmark

Strategic partnerships with pharma giants are accelerating the launch of new drugs, as confirmed by the EPS YoY growth dynamics, where the figure stood at 56.70. The business model of Neurocrine Biosciences (NBIX) relies on outsourcing production and research to reduce costs. Meanwhile, Ingrezza serves as the primary cash generator, although the market has already priced this growth into the quotes.

NBIX (Neurocrine Biosciences Inc) Earnings growth in current year history from 07/04/2022 to 11/18/2026

Financial and market metric breakdowns for Neurocrine Corp (NBIX)

Summary company analysis:Neurocrine Biosciences Inc (NBIX)
Brand item of Neurocrine Biosciences Inc

Assessing the asset quality of Neurocrine Biosciences (NBIX) requires an analysis of the monetization efficiency of its patented neurological disorder treatments through insurance funds. The EPS dynamics compared to the previous year measure the annual growth rate of net income per share, allowing investors to distinguish genuine business expansion from market noise and avoid overpaying for inflated capital expectations.

Direct competitors

Earnings per share growth rate in current year Biogen Idec (BIIB)|RGC (Regencell Bioscience Ltd) - Earnings growth in current year|Earnings per share growth rate in current year Axsome Therapeutics, Inc. AXSM|Net earnings per share growth this year ACAD (ACADIA Pharmaceuticals Inc.)|XENE: Earnings per share trend in current year|Viking Therapeutics, Inc. - Net earnings per share growth this year|Expected net earnings per share growth this year Supernus Pharmaceuticals (SUPN)|CPRX: Net earnings per share growth this year|Earnings per share increase in current year DNLI (Denali Therapeutics)|HRMY: Earnings growth in current year|BHVN (Biohaven Pharmaceutical) - Earnings per share growth in current year|Earnings per share growth in current year Amylyx|Earnings growth in current year Trevi Corp|Earnings growth in current year PRAX|AVXL (anavex.com) - Earnings per share increase in current year|CeriBell Inc - Net earnings per share growth this year|PRTA (Prothena Corporation plc) - Earnings per share trend in current year|ALEC - Earnings per share growth in current year|ANNX (Annexon Biosciences Inc.) - Earnings per share growth this year|OMER (omeros.com) - Net earnings per share growth this year|Earnings per share growth this year NGNE|Net earnings per share growth this year ACIU|Earnings growth in current year Voyager Pharma|Net earnings per share growth this year NMRA (Neumora Therapeutics, Inc.)|SCLX - Earnings per share growth rate in current year|Earnings per share growth in current year Tevogen Bio TVGN|Alpha Cognition Corp (ACOG) - Earnings per share growth rate in current year|CGTX: Net earnings per share growth this year|Inhibikase Therapeutics, Inc. - Net earnings per one share growth for the current year|SAVA: Earnings growth in current year|Earnings per share growth this year ASRT|COYA (coyatherapeutics.com) - Earnings growth in current year|Vistagen (VTGN) - Expected net earnings per share growth this year|Net earnings per share growth this year OVID (Ovid Rx)|Expected net earnings per share growth this year Acumen Pharmaceuticals, Inc.|Earnings growth in current year CRVO (CervoMed Corporation)|Net earnings per one share growth for the current year ATHE (Alterity Therapeutics Ltd)|Clene Nanomedicine - Earnings growth in current year|Net earnings per share change in current year pepgen.com (PEPG)|JUNS: Earnings growth in current year|Earnings per share growth this year RLMD|ANVS (Annovis Bio Inc) - Earnings growth in current year|Net earnings per share growth this year Grace Therapeutics, Inc. (GRCE)|Earnings growth in current year AIFF|Net earnings per one share growth for the current year KLTO|Earnings per share growth in current year neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings (RVPH) - Earnings per share growth rate in current year|MetaVia Inc. - Earnings growth in current year|Expected net earnings per share growth this year NeurAxis Inc NRXS|HSDT (Helius Medical Technologies Inc.) - Net earnings per share growth this year|Passage Bio Inc. (PASG) - Earnings growth in current year|Earnings per share growth in current year Neuphoria|Net earnings per share growth this year Minerva Neurosciences, Inc. (NERV)|Earnings per share growth in current year Athira (ATHA)|Addex Therapeutics - Earnings per share growth this year|Earnings per share growth in current year Alzamend Neuro, Inc. ALZN|Cyclerion (CYCN) - Earnings per share growth rate in current year|PTIX - Earnings per share growth in current year|Expected net earnings per share growth this year Pasithea Therapeutics Corp KTTA|Cortigent, Inc. (CRGT) - Earnings per share growth in current year|Avenue Therapeutics - Earnings per share increase in current year|BCLI (brainstorm-cell.com) - Earnings growth in current year|CARA: Earnings per share increase in current year|Earnings per share growth in current year Chromocell Therapeutics Corp (CHRO)|ELYM (Eliem Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year ITCI (Intra-Cellular Therapies Inc.)|Net earnings per share change in current year Longboard Pharma|MRNS - Earnings per share growth in current year|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth this year|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net earnings per share growth this year|Sage Therapeutics - Earnings per share increase in current year|Earnings per share growth in current year Synaptogenix, Inc.|TRVN: Earnings per share increase in current year|Earnings growth in current year VIGL|Net earnings per share growth this year Anew Medical, Inc. WENA|Earnings per share growth in current year Cerevel Therapeutics CERE